Acute mountain sickness
Information
- Disease name
- Acute mountain sickness
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT00326703 | Completed | N/A | Effects of Aircraft Cabin Altitude on Passenger Comfort and Discomfort | October 2002 | April 2003 |
NCT00559832 | Completed | N/A | Prevention of Acute Mountain Sickness by Intermittent Hypoxia | March 2006 | July 2007 |
NCT00603122 | Completed | N/A | Acclimatization Mechanisms During Ascent to 7500m | March 2005 | December 2005 |
NCT00627965 | Completed | Phase 4 | Randomized, Controlled Trial of Regular Sildenafil Citrate in the Prevention of Altitude Illness | March 2003 | February 2008 |
NCT00664001 | Completed | Phase 3 | Anti-Oxidant Supplementation for the Prevention of Acute Mountain Sickness | March 2003 | December 2003 |
NCT03390335 | Completed | N/A | Decompression Tables for Diving at Altitude | February 13, 2018 | October 29, 2021 |
NCT03424226 | Completed | Phase 1 | Sickness Evaluation at Altitude With Acetazolamide at Relative Dosages | August 4, 2018 | September 30, 2018 |
NCT03561675 | Completed | Phase 4 | Effect of Acetazolamide on Acute Mountain Sickness in Lowlanders Older Than 40 Years | May 15, 2018 | August 31, 2019 |
NCT03828474 | Completed | Phase 1 | Sickness Evaluation at Altitude With Acetazolamide at Relative Doses | August 9, 2019 | September 29, 2019 |
NCT04111263 | Completed | N/A | Gut-microbiota Targeted Nutritional Intervention for Gut Barrier Integrity at High Altitude | October 6, 2019 | November 5, 2022 |
NCT05023941 | Completed | Phase 4 | Optimization Strategy for the Prevention of AMS by RIPC Combined With Acetazolamide | December 1, 2021 | August 30, 2022 |
NCT05734716 | Completed | Phase 4 | Colorado-Oregon Altitude Study | February 17, 2021 | January 1, 2023 |
NCT05798416 | Completed | N/A | Effect of Inhalation of Low Dose CO2 on Exercise Performance at High Altitude | February 15, 2023 | April 29, 2023 |
NCT06310642 | Completed | Phase 4 | Efficacy of Prophylactic Treatment of Oral Prochlorperazine for Acute Mountain Sickness | May 20, 2021 | March 13, 2023 |
NCT01418157 | Completed | Phase 4 | A Trial of Acetazolamide Versus Placebo in Preventing Mountain Sickness During Rapid Ascent | August 2011 | October 2011 |
NCT01436383 | Completed | N/A | Oxidative Stress in Hypobaric Hypoxia | March 2005 | February 2010 |
NCT01468194 | Completed | N/A | Change in Peripheral Oxygen Saturation by Using Different Breathing Procedures in High Altitude | July 2011 | November 2011 |
NCT01522326 | Completed | N/A | Comparison of Metoclopramide and Ibuprofen for the Treatment of Acute Mountain Sickness | March 1, 2012 | March 30, 2017 |
NCT01536288 | Completed | Phase 2 | Can Rhodiola Crenulata Intake Improve Oxygen Saturation and Decrease the Incidence of Acute Mountain Sickness | October 2010 | May 2011 |
NCT01665781 | Completed | Phase 4 | Erythropoietin in the Prevention of Acute Mountain Sickness | August 2012 | March 2013 |
NCT01794130 | Completed | The Incidence of Subclinical High-altitude Pulmonary Oedema at High Altitude | July 2011 | July 2011 | |
NCT01842906 | Completed | N/A | Study Looking at End Expiratory Pressure for Altitude Illness Decrease (SLEEP-AID) | October 2013 | October 2014 |
NCT01902758 | Completed | Phase 2/Phase 3 | Drug Combination on Exercise Performance at High Altitude | August 2013 | August 2013 |
NCT02604173 | Completed | Phase 3 | Altitude Sickness Prevention and Efficacy of Comparative Treatments | August 2016 | September 2016 |
NCT02811016 | Completed | Phase 1 | Inhaled Budesonide and Acute Mountain Sickness | June 2016 | October 2016 |
NCT03154645 | Completed | Phase 1 | Altitude Sickness Prevention With Ibuprofen Relative to Acetazolamide and Treatment Efficacy | August 12, 2017 | October 1, 2017 |
NCT03270787 | Completed | Phase 1/Phase 2 | Study of Compound Danshen Dripping Pills to Treat Acute Mountain Sickness | June 24, 2016 | July 13, 2017 |
NCT06145113 | Not yet recruiting | N/A | The Effect of Continuous Positive Pressure Ventilation on Symptoms of Acute Mountain Sickness | March 10, 2024 | August 10, 2024 |
NCT06039475 | Recruiting | RISK FACTORS ASSOCIATED WITH HIGH ALTITUDE SICKNESS: A CASE-CONTROL STUDY | July 1, 2023 | November 30, 2023 | |
NCT05733338 | Recruiting | N/A | The Effects of Intermittent Hypoxia on Acute Hypoxic Injury | March 1, 2023 | April 30, 2023 |
NCT06450899 | Recruiting | Phase 2 | Prochlorperazine Maleate Versus Placebo for the Prophylaxis of Acute Mountain Sickness | August 2024 | July 2025 |
NCT06393998 | Recruiting | N/A | CO2 Supplement for Treatment of Acute Mountain Sickness | June 7, 2024 | August 15, 2024 |
NCT03956472 | Terminated | N/A | Alternative Treatments in Acute Mountain Sickness | June 17, 2017 | July 31, 2019 |
NCT01698619 | Unknown status | Hemodynamic Changes in Altitude Adaptation | August 2012 | December 2012 | |
NCT01565603 | Unknown status | Sleep and Cerebral Responses to High Altitude | July 2011 | October 2012 | |
NCT00886912 | Unknown status | N/A | Training in Hypoxia to Prevent Acute Mountain Sickness | June 2008 | October 2009 |
- MedGen concept unique identifier (MedGen Concept name)
- C0238284
- MedGen unique identifier (MedGen Concept name)
- 536790